Amorsa Therapeutics, Inc.
Pharmaceutical ManufacturingMassachusetts, United States2-10 Employees
Amorsa is pioneering the development of novel (patented) ketamine analogs for treating neuropsychiatric disorders including treatment resistant depression, PTSD and obsessive-compulsive disorder.